Harvard Titles
Adjunct Professor Epidemiology, Harvard T.H. Chan School of Public Health
Lecturer on Medicine, Part-time
Other Affiliations
Channing Division of Network Medicine, Brigham and Women's Hospital
Address
Channing Laboratory
181 Longwood Avenue, 4th Floor, Room 444
Boston, MA 02115
Publications View
Carboplatin/mitomycin C (MMC) as salvage therapy with intraindividual dose escalation in advanced breast cancer
Authors: Fazeny B, Stubenvoll R, DeSantis M, Poehnl R, Soucek B, Schernhammer E, Postner G, Kienzer H, Kraus R, Pont J, Dittrich CH
Pro ASCO, Los Angeles, CA
Pro ASCO, Los Angeles, CA
Pharmacokinetic interaction between 4'-epidoxorubicin and the multidrug resistance reverting agent quinine.
Authors: Czejka M, Bandak S, Simon D, Schüller J, Weiss C, Schernhammer E.
Z Naturforsch C J Biosci
View full abstract on Pubmed
Z Naturforsch C J Biosci
View full abstract on Pubmed
[Drug interactions between interferon alpha 2b and 5-fluorouracil during continuous intravenous 5FU infusion].
Pharmacokinetic drug interaction between epirubicin and interferon-alpha-2b in serum and red blood cells.
Authors: Bandak S, Czejka M, Schüller J, Schernhammer E.
Arzneimittelforschung
View full abstract on Pubmed
Arzneimittelforschung
View full abstract on Pubmed
Dexverapamil to overcome epirubicin resistance in advanced breast cancer.
Authors: Thürlimann B, Kröger N, Greiner J, Mross K, Schüller J, Schernhammer E, Schumacher K, Gastl G, Hartlapp J, Kupper H, et al.
J Cancer Res Clin Oncol
View full abstract on Pubmed
J Cancer Res Clin Oncol
View full abstract on Pubmed
Pharmacokinetic interaction between 4’-epidoxorubicin and the multidrug resistance reverting agent quinine
Authors: Czejka M, Bandak S, Simon D, Schueller J, Weiss C, Schernhammer E
Z Naturforschung
Z Naturforschung
Epirubicin pharmacokinetics, influence of interferon alfa 2b in advanced cancer patients
Authors: Schueller J, Czejka M, Bandak S, Wirth M, Schernhammer E, Schernthaner G
Pro ASCO, Dallas, TX
Pro ASCO, Dallas, TX
Melatonin and Cancer [invited book chapter]
Authors: Schernhammer ES
‘Melatonin: From Molecules to Therapy’
‘Melatonin: From Molecules to Therapy’
Insulin-like growth factor receptor (IGFR-I) as a target for future therapeutic interventions [invited book chapter]
Authors: Schernhammer E, Enzinger P
‘Signaltransduktion in der Onkologie – Grundlagen und therapeutische Möglichkeiten’ [German]
‘Signaltransduktion in der Onkologie – Grundlagen und therapeutische Möglichkeiten’ [German]
Serum and tissue levels of d- and 1- Methyltetrahydrofolic acid (MTHF) after i.v
Authors: Schueller J, Czejka M, Bandak S, Schernhammer E, Schernthaner G
bolus of (d,1) MTHF
bolus of (d,1) MTHF